Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

Social

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Friend.Tech User Dumps Keys Worth $1.5M, Switches to Bitcoin dApp
Friend.Tech User Dumps Keys Worth $1.5M, Switches to Bitcoin dApp

Newer opportunities have stalled Friend.Tech’s initial growth wave, and applications such as New Bitcoin City are quickly emerging as one of the biggest bets.

Coindesk·2023/10/23 23:58
A Brief Discussion on Inbound Traffic for Crypto — Telegram, Discord & PWA
A Brief Discussion on Inbound Traffic for Crypto — Telegram, Discord & PWA

The trajectory of inbound traffic depends heavily on two factors: user experience and regulatory considerations.

TokenInsight·2023/10/19 10:30
Friend.tech Profit Strategy  |  Crypto Daily Digest Sep.27
Friend.tech Profit Strategy | Crypto Daily Digest Sep.27

Despite a very cold market overall, Friend.tech has shown no signs of fading. Several strategy has been proposed to profit from this social application.

TokenInsight·2023/09/27 15:36
TON Chain and Telegram |  Crypto Daily Digest Sep.18
TON Chain and Telegram | Crypto Daily Digest Sep.18

The latest partnership between TON chain and Telegram sparked renewed interest in TON.

TokenInsight·2023/09/18 12:48
Friend.tech Resugred Due to Token Anticipation |  Crypto Daily Digest Sep.11
Friend.tech Resugred Due to Token Anticipation | Crypto Daily Digest Sep.11

Friend.tech has seen a sudden resurge in both TVL and transaction volume. Several factors have contributed to its comeback.

TokenInsight·2023/09/11 14:00
Is Friend.tech Dead? |  Crypto Daily Digest Aug. 31
Is Friend.tech Dead? | Crypto Daily Digest Aug. 31

After the initial success, the trading volume of Friend.tech dropped 95% over the past week. Some crypto KOLs even declared it dead.

TokenInsight·2023/08/31 15:36
Nation States Mining Bitcoin |  Crypto Daily Digest Aug. 29
Nation States Mining Bitcoin | Crypto Daily Digest Aug. 29

One notable bullish trend has been the active involvement of nation states in the bitcoin mining industry

TokenInsight·2023/08/29 15:42
Friend.tech Gaining Momentum |  Crypto Daily Digest Aug. 22
Friend.tech Gaining Momentum | Crypto Daily Digest Aug. 22

The latest update you need to know about Friend.tech

TokenInsight·2023/08/22 15:31
Sell Shares of Your X (Twitter)  |  Crypto Daily Digest Aug. 14
Sell Shares of Your X (Twitter) | Crypto Daily Digest Aug. 14

Last week, friend.tech, a new social crypto-based social application went live and become popular on Crypto Twitter

TokenInsight·2023/08/14 14:18
Ethcc Projects Updates |  Crypto Daily Digest July. 21
Ethcc Projects Updates | Crypto Daily Digest July. 21

2023 Ethcc was held in Paris between July 17 to 20, many projects have announced their latest updates. Today, we share 3 important announcements that could bring significant impact.

TokenInsight·2023/07/21 13:31
Flash
21:04
Bryan Armstrong says cryptocurrency is driving global access to capital and investment
Bryan Armstrong stated that billions of people are unable to access financial tools due to restrictions based on their place of birth, but cryptocurrency is enabling global access to funds and investments through mobile phones. (Cointelegraph)
20:53
Chicago wheat futures fell about 2.6%, soybean meal dropped 2.5%, and soybean oil rose over 1.3%.
CBOT corn futures fell 0.72%, quoted at $4.4525 per bushel. CBOT wheat futures dropped 2.58%, quoted at $5.7625 per bushel, remaining roughly stable around $5.90 before 21:44 (UTC+8), but accelerated downward after the US stock market opened. CBOT soybean futures fell 0.77%, quoted at $11.6175 per bushel; soybean meal futures dropped 2.50%, while soybean oil futures rose 1.34%.
20:49
Eli Lilly's Chief Financial Officer recently stated that its oral GLP-1 receptor agonist Orforglipron could enter the US market as early as the second quarter of this year, following expected regulatory approval in April.
This timeline has been confirmed by investment bank TD Cowen. If this pill formulation successfully enters the market, it will break through the current limitation of GLP-1 drugs requiring injection administration, providing a more convenient treatment option for diabetes and obesity patients. Market analysis points out that the oral formulation is expected to significantly improve drug accessibility and may further expand Eli Lilly's market advantage in the field of metabolic disease treatment.